Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Communique-de-presse-Le-CHMP-recommande-l-approbation-de-Beyfortus-nirsevimab-pour-la-preve-41787699/?utm_source=whatsapp&utm_medium=social&utm_campaign=share